Tags

Type your tag names separated by a space and hit enter

[Buflomedil and nicergoline in the targeted treatment of acute cerebral ischemia. Randomized comparative double blind study].

Abstract

Acute cerebral ischaemia may take considerable advantages of an adequate intensive therapy associated with a specific treatment of cerebral oedemas, especially in terms of mortality-rate reduction. Moreover, target treatment of acute cerebral ischaemia may produce excellent results in severe cases selected by means of EEG-chronospectrography. Double-blind, randomized comparison between nicergolin and buflomedil especialls showed that the latter reduces mortality three times as much as nicergolin, and leads to a 200% increment in the complete recovery of the "functio laesa", limited to those cases, which showed an appreciable improvement following EEG-chronospectrographical survey.

Authors

Source

Minerva medica 76:21 1985 May 19 pg 1005-18

MeSH

Acute Disease
Aged
Brain Ischemia
Cerebrovascular Circulation
Clinical Trials as Topic
Double-Blind Method
Drug Evaluation
Electroencephalography
Ergolines
Female
Humans
Male
Middle Aged
Nicergoline
Pyrrolidines
Random Allocation

Pub Type(s)

Clinical Trial
Comparative Study
English Abstract
Journal Article
Randomized Controlled Trial

Language

ita

PubMed ID

3889723

Citation

Bossi, L. "[Buflomedil and Nicergoline in the Targeted Treatment of Acute Cerebral Ischemia. Randomized Comparative Double Blind Study]." Minerva Medica, vol. 76, no. 21, 1985, pp. 1005-18.
Bossi L. [Buflomedil and nicergoline in the targeted treatment of acute cerebral ischemia. Randomized comparative double blind study]. Minerva Med. 1985;76(21):1005-18.
Bossi, L. (1985). [Buflomedil and nicergoline in the targeted treatment of acute cerebral ischemia. Randomized comparative double blind study]. Minerva Medica, 76(21), pp. 1005-18.
Bossi L. [Buflomedil and Nicergoline in the Targeted Treatment of Acute Cerebral Ischemia. Randomized Comparative Double Blind Study]. Minerva Med. 1985 May 19;76(21):1005-18. PubMed PMID: 3889723.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Buflomedil and nicergoline in the targeted treatment of acute cerebral ischemia. Randomized comparative double blind study]. A1 - Bossi,L, PY - 1985/5/19/pubmed PY - 1985/5/19/medline PY - 1985/5/19/entrez SP - 1005 EP - 18 JF - Minerva medica JO - Minerva Med. VL - 76 IS - 21 N2 - Acute cerebral ischaemia may take considerable advantages of an adequate intensive therapy associated with a specific treatment of cerebral oedemas, especially in terms of mortality-rate reduction. Moreover, target treatment of acute cerebral ischaemia may produce excellent results in severe cases selected by means of EEG-chronospectrography. Double-blind, randomized comparison between nicergolin and buflomedil especialls showed that the latter reduces mortality three times as much as nicergolin, and leads to a 200% increment in the complete recovery of the "functio laesa", limited to those cases, which showed an appreciable improvement following EEG-chronospectrographical survey. SN - 0026-4806 UR - https://www.unboundmedicine.com/medline/citation/3889723/[Buflomedil_and_nicergoline_in_the_targeted_treatment_of_acute_cerebral_ischemia__Randomized_comparative_double_blind_study]_ DB - PRIME DP - Unbound Medicine ER -